The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Long-term harms from previous use of selective serotonin reuptake inhibitors: A systematic review
Open accessAbstract
BACKGROUND: Millions of people are treated with antidepressants like selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). This clinical practice is based on short-term trials that have exaggerated the benefits and underestimated the harms. We also know too little about long-term harms. AIM: To assess harms of SSRIs and SNRIs that persist after end of drug intake. METHODS: Systematic review of placebo-controlled randomised trials of any length in patients with a psychiatric diagnosis and a follow-up of at least six months. Our primary outcomes were mortality, functional outcomes, quality of life and core psychiatric events. We searched PubMed, Embase, and the Cochrane Central Register of Controlled Trials and checked the references for eligible articles. One researcher extracted data and another checked the data extraction. RESULTS: Our searches returned 9,153 unique records. We included 22 papers for 12 trials on SSRIs. Median intervention and follow-up periods were 15 and 52 weeks, respectively. Median number of randomised participants was 51; only two trials had a drop-out rate below 20%. Outcome reporting was less thorough during follow-up than for the intervention period and only two trials maintained the blind during follow-up. All authors concluded that the drugs were not beneficial in the long term. All trials reported harms outcomes selectively or did not report any. Only two trials reported on any of our primary outcomes (school attendance and number of heavy drinking days). CONCLUSION: The randomised trials currently available cannot be used to investigate persistent harms of antidepressants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, the symptoms are physical as well as emotional and for some they persist for months or years,21–23 sometimes even after a very slow and careful taper.13,19”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hao (2015) · doi:10.1002/14651858 · Cited by 11,321
Exercise and Pharmacotherapy in the Treatment of Major Depressive Disorder
Blumenthal, J. A., Babyak, M. A., Doraiswamy, P. M., Watkins, L., Hoffman, B. M., Barbour, K. A., Herman, S., Craighead, W. E., Brosse, A. L., Waugh, R., et al. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318148c19a · Cited by 1,019
Ho, B.-C., Andreasen, N. C., Ziebell, S., Pierson, R., & Magnotta, V. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.199 · Cited by 971 · cited 1×
“Long-term use of psychiatric drugs may cause permanent brain damage, which has been most clearly documented for antipsychotics [20, 21].”
BackgroundDorph-Petersen, K.-A., Pierri, J. N., Perel, J. M., Sun, Z., Sampson, A. R., & Lewis, D. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300710 · Cited by 437 · cited 1×
“Long-term use of psychiatric drugs may cause permanent brain damage, which has been most clearly documented for antipsychotics [20, 21].”
BackgroundFava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436 · cited 4×
“It is well known that harms caused by SSRIs can be long-lasting [18] and there are indications that they can even be permanent, e.”
BackgroundInfluentialZimmerman, M., Mattia, J. I., & Posternak, M. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.469 · Cited by 382 · cited 1×
“in a study that showed that only 41 of 346 (12%) outpatients would qualify for a clinical trial based on common inclusion and exclusion criteria for antidepressant efficacy trials [49].”
BackgroundJakobsen, J. C., Katakam, K. K., Schou, A., Hellmuth, S. G., Stallknecht, S. E., Leth-Møller, K., Iversen, M., Banke, M. B., Petersen, I. J., Klingenberg, S. L., et al. (2017) · BMC Psychiatry · doi:10.1186/s12888-016-1173-2 · Cited by 366 · cited 1×
“Inadequate reporting of harms, even serious harms like deaths, is a general problem for psychiatric drug trials [6, 8, 45, 46], and the discrepancy between data in clinical study reports and in journal publications is disturbing [7, 12, 47, 48].”
BackgroundSharma, T., Guski, L. S., Freund, N., & Gøtzsche, P. C. (2016) · BMJ · doi:10.1136/bmj.i65 · Cited by 319 · cited 3×
“The trials are of short duration, a median of only 9 weeks [8]; withdrawal effects are almost always introduced in the placebo group because the patients were already in treatment before they were randomised; lack of effective blinding; attrition; and selective reporting of major harms [6–8].”
BackgroundSelf-citationAntidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286
Golder, S., Loke, Y. K., Wright, K., & Norman, G. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002127 · Cited by 277 · cited 1×
“Inadequate reporting of harms, even serious harms like deaths, is a general problem for psychiatric drug trials [6, 8, 45, 46], and the discrepancy between data in clinical study reports and in journal publications is disturbing [7, 12, 47, 48].”
Background
Research works printed but not linked: 4
- Boesen K, 2017, Cochrane Database of Systematic Reviews, CD012857
- DanborgPB SimonsenAL HróbjartssonA GøtzschePC. Long-term changes in observed behavior after exposure to psychiatric drugs: A systematic review of animal studies. Published online, http://nordic.cochrane.org/sites/nordic.cochrane.org/files/public/uploads/danborg_2017_long-term_harms_animal_study.pdf
- SharmaT. Effects of selective serotonin reuptake inhibitors (SSRIs) and serotonin - norepinephrine reuptake inhibitors (SNRIs) on suicidality, violence, and quality of life (PhD Thesis): University of Copenhagen; 2018.
- Tonge BJ, 2013, RANZCP, 47, 59
Cited by
Canadian Guideline for the Clinical Management of High-Risk Drinking and Alcohol Use Disorder
Wood, E., Bright, J., Hsu, K., Goel, N., Ross, J. W. G., Hanson, A., Teed, R., Poulin, G., Denning, B., Corace, K., et al. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.230715 · Cited by 74
“61 Although there is a relatively high degree of consistent findings across naltrexone and acamprosate trials, 18 studies of SSRIs are highly heterogenous, potentially as a result of underlying biases described elsewhere.”
BackgroundWhite, E., Read, J., & Julo, S. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320981174 · Cited by 63
da Silva, F. J. B., Santos, M. C., & Tesser, C. D. (2022) · Interface - Comunicação Saúde Educação · doi:10.1590/interface.210558 · Cited by 12
What do Climate Change, Nutrition, and the Environment Have to do With Mental Health?
Sugden, S. G., & Merlo, G. (2024) · American Journal of Lifestyle Medicine · doi:10.1177/15598276241280245 · Cited by 10
“5 There are limited long-term randomized clinical controlled trials that con fi rm their ef fi cacy 6 despite the chronicity of depression.”
What have antidepressants been tested for? A systematic review
Gøtzsche, P. C., & Dinnage, O. (2020) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-200006 · Cited by 8
“When our research group screened a large amount of papers for a review on long-term harms of antidepressants [3], we noticed that they had been tested for a surprisingly wide range of everyday problems.”
Self-citation
Metadata
- Authors
- Danborg, P. B., Valdersdorf, M., & Gøtzsche, P. C.
- Affiliations
- Rigshospitalet (DK)
- Corresponding author
- Gøtzsche, P.C.
- ORCID
- Gøtzsche, P.C.
- Venue
- International Journal of Risk & Safety in Medicine
- Publisher
- SAGE Publications
- Published
- 2019-05
- Volume
- 30
- Issue
- 2
- Pages
- 59-71
- ISSN
- 0924-6479 (ISSN-L)
- 1878-6847
- PMC
- PMC6839490
- OpenAlex
- W2911290550
- Cited by
- 14
- References
- 57
- Citations by year
- 2026: 3 · 2024: 3 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 2
- FWCI
- 0.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- International Journal of Risk & Safety in Medicine (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, antidepressants, mortality, functional outcome, quality of life, school attendance, heavy drinking, outcome reporting, trial design limitations
- MeSH terms
- Serotonin and Noradrenaline Reuptake Inhibitors, Long Term Adverse Effects, Depression, Humans, Selective Serotonin Reuptake Inhibitors, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-term harms from previous use of selective serotonin reuptake inhibitors: A systematic review. https://app.cochat.ai/papers/10.3233/jrs-180046
- The paper
- Danborg, P. B., Valdersdorf, M., & Gøtzsche, P. C. (2019). Long-term harms from previous use of selective serotonin reuptake inhibitors: A systematic review. International Journal of Risk & Safety in Medicine. https://doi.org/10.3233/jrs-180046
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.